Literature DB >> 27741154

An Advanced In Vitro Technology Platform to Study the Mechanism of Action of Prebiotics and Probiotics in the Gastrointestinal Tract.

Massimo Marzorati1, Tom Van de Wiele.   

Abstract

The gastrointestinal tract (GIT) hosts the most complex microbial community in the human body. Given the extensive metabolic potential which is present in this community, this additional organ is of key importance to maintain a healthy status and several diseases are frequently correlated with an alteration of the composition/functionality of the gut microbiota. Consequently, there is a great interest in identifying potential approaches that could modulate the microbiota and its metabolism to bring about a positive health effect. A classical approach to reach this goal is the use of prebiotics and/or probiotics. How to study the potential effect of new prebiotics/probiotics and how to localize this effect along the full GIT? Human intervention trials are the golden standard to validate functional properties of food products. Yet, most studies on gut microbiota are based on the analysis of fecal samples because they are easily collected in a non-invasive manner. A complementary option is represented by well-designed in vitro simulation technologies. Among all the available systems, the Simulator of Human Intestinal Microbial Ecosystem has already been shown to be a useful model for nutrition studies in terms of analysis of the intestinal microbial community composition and activity. The Simulator of Human Intestinal Microbial Ecosystem is a scientifically validated platform representing the physiology and microbiology of the adult human GIT. Furthermore, recent advances in in vitro modelling also allow to combine the study of bacteria-host interactions, such as mucosal adhesion and interaction with the immune system, thereby further increasing the value of the scientific output.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27741154     DOI: 10.1097/MCG.0000000000000711

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  5 in total

1.  Protection from chemotherapy- and antibiotic-mediated dysbiosis of the gut microbiota by a probiotic with digestive enzymes supplement.

Authors:  Thomas E Ichim; Santosh Kesari; Kim Shafer
Journal:  Oncotarget       Date:  2018-07-20

2.  Xylitol enhances synthesis of propionate in the colon via cross-feeding of gut microbiota.

Authors:  Shasha Xiang; Kun Ye; Mian Li; Jian Ying; Huanhuan Wang; Jianzhong Han; Lihua Shi; Jie Xiao; Yubiao Shen; Xiao Feng; Xuan Bao; Yiqing Zheng; Yin Ge; Yalin Zhang; Chang Liu; Jie Chen; Yuewen Chen; Shiyi Tian; Xuan Zhu
Journal:  Microbiome       Date:  2021-03-18       Impact factor: 14.650

3.  Perspective: Leveraging the Gut Microbiota to Predict Personalized Responses to Dietary, Prebiotic, and Probiotic Interventions.

Authors:  Sean M Gibbons; Thomas Gurry; Johanna W Lampe; Anirikh Chakrabarti; Veerle Dam; Amandine Everard; Almudena Goas; Gabriele Gross; Michiel Kleerebezem; Jonathan Lane; Johanna Maukonen; Ana Lucia Barretto Penna; Bruno Pot; Ana M Valdes; Gemma Walton; Adrienne Weiss; Yoghatama Cindya Zanzer; Naomi V Venlet; Michela Miani
Journal:  Adv Nutr       Date:  2022-10-02       Impact factor: 11.567

Review 4.  What We Know So Far about the Metabolite-Mediated Microbiota-Intestinal Immunity Dialogue and How to Hear the Sound of This Crosstalk.

Authors:  Clément Caffaratti; Caroline Plazy; Geoffroy Mery; Abdoul-Razak Tidjani; Federica Fiorini; Sarah Thiroux; Bertrand Toussaint; Dalil Hannani; Audrey Le Gouellec
Journal:  Metabolites       Date:  2021-06-21

5.  Impact of Cumulative Environmental and Dietary Xenobiotics on Human Microbiota: Risk Assessment for One Health.

Authors:  Pilar Ortiz; Alfonso Torres-Sánchez; Ana López-Moreno; Klara Cerk; Ángel Ruiz-Moreno; Mercedes Monteoliva-Sánchez; Antonis Ampatzoglou; Margarita Aguilera; Agnieszka Gruszecka-Kosowska
Journal:  J Xenobiot       Date:  2022-03-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.